Fibrocell Science, Inc. FCSC Cash Flow

Fibrocell science, inc. (FCSC)

CashFlow / Quarterly

Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Cash flows from operating activities:
Net Income (Loss) Attributable to Parent
-7,227	11,766	-3,666	-1,646	-2,859	-2,894	-2,901	2,900	-115	-14,018	-5,007	-3,494	-2,299	-8,092	-1,407	-17,651	-1,521	-6,756	-8,525	-3,372	-6,012	-2,257	-14,009	-	-	-	-	-11,048	11,437	-9,114	-3,962	-	-	-	-
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-4,570	-	-	-	-	-	-	-	-
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-17,062
Stock-based compensation expense
82	117	112	133	133	131	129	128	131	112	-49	317	491	580	545	488	506	804	240	234	266	436	303	222	719	36	173	367	275	275	307	260	237	1,350	1,051
Stock issued for supplemental stock issuance agreement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	5,154	-	-	-	-	-	-	-	-	-	-	-	-
Warrant liability revaluation income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,795	177	4,008	-3,050	-	-	-	-	-	-	-	-	-	-	-	-
Warrant Revaluation Income (Expense)
141	37	-29	-	265	91	235	-	4,981	-9,677	-46	-	3,007	2,254	5,257	-	5,301	602	-1,663	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warrant revaluation and other finance (income) expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,338	-	-	-	-	-	-	-	-6,296
Warrant income (expense)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-501	-	-	-	-
Unrealized Gain (Loss) on Derivatives
-3,517	-1,183	100	1,400	121	279	-100	-1,694	-254	853	-312	-211	-251	0	0	-	-	-	-	-	-	-	-	-	-	-	-	0	1,894	-1,951	34	-	-	-	-6,620
Deferred tax benefit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	2,500	-	-	-	-
Loss on disposal or impairment of property and equipment
-	-	-	-	-	-	-	0	0	-10	-30	-5	3,906	-3,970	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization of long lived assets
83	83	85	90	100	101	101	102	98	93	91	88	85	174	217	213	208	206	140	210	221	230	222	170	237	230	226	217	212	201	191	82	63	10	2
Recovery of doubtful accounts
-	-	-	-	-	-	-	-	-	-	-	0	0	-2	-10	0	-4	-1	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on write-down of inventory
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-3	10	-22	-29	-0	5
Provision for doubtful accounts
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1	11	5	-	-	-	-9	-	-	0	-16	33	-2	-3	-8
Amortization of debt issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	34	9	3	100	-	-	-	-
Decrease (increase) in operating assets:
Foreign exchange gain on substantial liquidation of foreign entity
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	0
Accounts receivable
-	-	-	-	-	-	-	-	-	-	-	0	0	-2	-10	0	-7	-1	-1	-1	-13	-33	35	-31	-33	55	-45	-22	49	23	10	14	-6	62	-65
Other receivables
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-6	1	5	-3	1	-1
Inventory
-	-	-	-	-	-	-	-	-	-	-	356	-260	-215	-7	-84	82	-60	-27	-39	134	-30	-91	-	-	-	-	171	-13	-29	348	-71	20	-32	45
Prepaid expenses and other current assets
400	-406	1,112	-151	-199	-30	0	220	-176	-123	51	249	-317	-429	-299	777	-263	-348	-201	-	-226	-179	-317	-	670	-371	-166	-	-	-	-	-	-	-	-
Prepaid expenses and other current assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	770	-147	-303	-124	-380	1,018	20	-221
Other assets
-	-	-39	-	-	-	12	-22	-23	-15	34	1	0	34	30	0	0	0	0	0	0	-142	-72	-	-	-	-	-	-	-	-	-	-	-	-
Increase (decrease) in operating liabilities:
Accounts payable
613	-575	1,060	-282	207	28	23	-63	-60	247	-55	73	-209	-341	338	-1,012	-163	768	293	839	-314	465	-2,055	559	27	-103	324	-780	1,028	-271	-943	849	279	229	-555
Related party payable
-3,743	3,762	-47	37	-213	-98	-1,929	572	53	169	567	601	-583	-154	-9,642	9,285	772	-1,274	936	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued expenses, deferred rent
376	-332	265	486	-149	116	-190	182	252	11	-787	-161	465	620	-1,138	393	-351	-15	614	-799	487	275	931	-785	943	112	-82	-13	-134	325	229	-	-	-	-
Accrued lease liabilities - operating lease
-43	-39	16	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued interest payable
200	199	197	196	193	192	190	187	187	185	183	182	46	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Increase in accrued expenses and other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	813	63	238
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	0	-408	-54	5	-16	-27	-88	172	-63	199	131	1	16	-18	5	6	3	5	32	43	42	13	-14	14
Net Cash Provided by (Used in) Operating Activities
-6,685	2,500	-3,100	-2,483	-2,741	-2,715	-4,761	-4,158	-3,896	-4,229	-4,754	-3,794	-4,743	-4,790	-16,063	-7,626	-5,693	-6,549	-4,238	-6,784	-5,226	-4,333	-5,953	-4,036	-5,622	-5,358	-5,059	-7,318	-3,935	-5,013	-6,309	-4,558	-5,675	-3,448	-3,154
Cash flows from investing activities:
Purchase of property and equipment
253	78	9	9	72	48	35	85	105	156	87	66	44	85	58	63	97	3	108	-65	96	132	79	198	40	22	100	20	114	138	221	783	86	683	17
Net cash used in investing activities
-253	-78	-9	-9	-72	-48	-35	-85	-105	-156	-87	-66	-43	-85	-58	-37	-97	-3	-108	65	-96	-132	-79	-198	-40	-22	-100	-20	888	-138	-221	-783	-86	-683	-17
Cash flows from financing activities:
Proceeds from 2017 Series A Preferred Stock Offering, (net of offering costs of $377)
-	-	-	-	-	-	-	-	0	-263	7,886	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payment of deferred offering costs
15	0	22	0	0	0	444	0	0	0	0	-92	25	59	50	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from conversion of pre-funded warrants
-	-	0	-	-	-	24	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from the exercise of stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	103	152	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from the exercise of stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Principal payments on capital lease obligations
-	-	-	-	-	-	-	-	-	-	-	0	0	0	2	0	1	2	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on insurance loan
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	25	37	35	24	8	24	24
Dividends paid on preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	313	48	53	56	64	254	106	198
Proceeds from financing activity
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Net cash provided by (used in) financing activities
-15	0	-22	828	3,514	5,972	-420	9,749	0	-263	7,886	92	17,908	-59	-52	0	15,871	101	152	0	0	0	0	47,392	1,726	4	0	38,566	607	3,531	-91	1,302	17,997	3,423	5,613
Effect of exchange rate changes on cash balances
0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net decrease in cash and cash equivalents
-6,907	2,353	-3,108	-	701	3,209	-5,216	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Effect of exchange rate changes on cash balances
-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-1	-	-	-	-	-1	-1	4	1
Net decrease in cash and cash equivalents
-	-	-	-	-	-	-	5,506	-4,001	-4,648	3,045	-3,768	13,122	-4,934	-16,173	-7,663	10,081	-6,451	-4,194	-6,720	-5,321	-4,465	-6,032	43,158	-3,935	-5,376	-5,160	31,228	-2,440	-1,620	-6,621	-4,041	12,233	-703	2,442
Supplemental disclosures of cash flow information:
Property and equipment in accounts payable
-27	111	46	-63	20	19	33	0	3	13	13	24	-13	31	15	-20	31	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Offering costs in accounts payable and accrued expenses
-	0	15	-	-	100	0	444	0	-263	263	-18	30	-30	41	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Reduction of warrant liability upon cashless exercise of warrants
-	-	-	-	-	-	-	0	0	0	41	0	0	0	0	0	82	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividend paid in-kind to preferred stockholders
89	86	85	86	85	83	82	82	82	80	20	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Preferred Stock, Deemed Dividend
150	145	140	136	130	126	121	118	111	136	3,734	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-